We’ve just wrapped up an incredible YSC Chat with Luminaries event! ✨ An inspiring lineup of luminaries, highly engaged participants, and a vibrant exchange of ideas that kept the conversation going long after the session officially ended 🗣️ #CRS2025 #CRS2025YSC @CRSScience

2nd Industry round at #CRS2025 - YSC Industry Career Panel 🗓️ Thursday, July 17 | 2:00 - 3:00 PM | Room 122B 🗣️ @AshfordFell, Nishant Kulkarni, @sesnogueira, @ncscientist 🧭 Quim Peña & @Amy_R_Logan Sponsor: @AstraZeneca #CRS2025YSC #IndustryCareer #Networking @CRSScience

🚀 @CRS_YSC webinar duet on Artificial Intelligence in Drug Delivery and Therapy: From Research to the Clinic. 📢Join Dr. Frantz Le Devedec & Prof. Muhammad Mamdani for an insightful discussion on the future of medicine! 🔗 Registration link coming next week! @CRSScience

A nice way to end the year. Big thank you to @MK_CCI for all of your mentorship and support over the years. Looking forward to continuing to work together on developing new therapies for childhood cancer!

Looking forward to another year with @CRS_YSC. We've just had our first meeting for the 2024/2025 term. Great to meet all our new members, it's sure to be a productive year!

I have loved my time as a member @CRS_YSC and the chance to meet so many people from across the 🌎. If you are a young scientist in drug delivery and are passionate about creating networking and professional development opportunities for your peers, apply now!

We are thrilled to host Dr. Sadra Bakhshandeh @SadraBakh, Senior Editor @natrevbioeng and hear his insight on the scientific publishing landscape and the editorial processes. Thank you! @ronachandrawati @TKumeria @KrisKilian @MK_CCI @Amy_R_Logan

@MK_CCI @AustralianCRS @KidsCancerInst @NanoMed_UNSW @UNSWRNA @UNSWMedicine

A great week at #CRS2024 in Bologna, Italy. Amazing science, talks, and a good opportunity to connect with old and new friends. Proud to have contributed to organisation of many popular @CRS_YSC events. And a lovely way to finish the week with an oral talk prize. 😊

Another great YSC session at #CRS2024 this morning. So wonderful to hear from all of our luminaries and so many interesting questions from the audience!

Great presentation from @SanthniSub at #CRS2024 on the impact of proteins in extracellular fluid on delivery of nanoparticles in cancer vs normal tumour. Check out poster 812! @AustralianCRS @ClivePrestidge @Paul_Joyce_

📢Starting in one hour in room Magenta B! #CRS2024 @CRSScience

Very happy to be in Bologna for #CRS2024. Great meeting so far! Thank you to @AustralianCRS for helping to fund my travel. Looking forward to 5 days of science and networking @KidsCancerInst

🚀 Excited to see our paper out on targeting non-small cell lung cancer (NSCLC) with precision. EGFR-targeted liposomal therapy shows promise in enhancing treatment efficacy while reducing side effects. #NSCLC #PrecisionMedicine https://t.co/MqxU1zryYI @ernest_moles

Thanks to my supervisors @MK_CCI @ernest_moles @DrJoshMcCarroll and collaborators @ZerongMa @ThurechtGroup for their valuable help and support with the project

Excited to finally share the first paper from my PhD published in #j_controlled_release. We used bispecific #antibodies to deliver siRNA #lipid #nanoparticles to #neuroblastoma. @KidsCancerInst @UNSWMedicine @NanoMed_UNSW @UNSWRNA

Excited to share our latest paper Targeted delivery of siRNA nanoparticles for neuroblastoma. Well done @Amy_R_Logan on 1st paper from PhD. See thread on key findings. @ernest_moles @KidsCancerInst @NeuroblastomaAU @NanoMed_UNSW @UNSWRNA

Very excited to join the CRS Young Scientist Committee. Looking forward to working with everyone else from across the globe and planning some great events. @CRS_YSC @AustralianCRS @CRSScience

Gotta love an when your outfit unintentionally matches the slides 😂. Very grateful to have won best oral presentation. Thanks to all the organisers of #DDA2023 for another great opportunity to chat science with so many wonderful researchers.

Great final PhD seminar from @aminchacaacosta ! Learning about the surfaceome in HGGs, and the potential of ER chaperones as new therapeutic targets. So great to see all your hard work put together in such an interesting story. @MK_CCI @KidsCancerInst @thekca @UNSWMedicine